Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 447, 115-129
Abstract
No abstract availableKeywords
Funding Information
- Irish Cancer Society (CRS15BUC)
- Health Research Board (HRB ILP-POR-2017-055)
- Enterprise Ireland Commercialisation Fund (CF-2011-1319)
This publication has 55 references indexed in Scilit:
- The role of IL-6 in the radiation response of prostate cancerRadiation Oncology, 2013
- Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1αCell Death & Disease, 2013
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsScientific Reports, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signallingInternational Journal of Radiation Biology, 2009
- Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivoBritish Journal of Cancer, 2008
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995
- On the Origin of Cancer CellsScience, 1956